1. Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis
- Author
-
Hee Chul Nam, Do Seon Song, Da In Kim, U Im Chang, Jin Mo Yang, and Ji Won Han
- Subjects
Liver Cirrhosis ,Sarcopenia ,medicine.medical_specialty ,Cirrhosis ,H&E stain ,Myostatin ,Chronic liver disease ,Rifaximin ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Internal medicine ,medicine ,Animals ,Humans ,Molecular Biology ,Hepatology ,biology ,Tumor Necrosis Factor-alpha ,business.industry ,Skeletal muscle ,musculoskeletal system ,medicine.disease ,Rats ,Endocrinology ,medicine.anatomical_structure ,Liver ,chemistry ,biology.protein ,Tumor necrosis factor alpha ,Thioacetamide ,business - Abstract
Background/Aims: Sarcopenia is an independent prognostic factor of liver cirrhosis (LC). However, the association between LC-related systemic inflammation and sarcopenia is unclear.Methods: Sprague-Dawley rats were treated with thioacetamide (TAA) or saline as a control. Rifaximin was administered to TAA-induced LC rats. Enzyme-linked immunosorbent assay was performed to measure inflammatory mediators in rat serum. RT-PCR was performed to measure the molecular expression in tissues. Hematoxylin and eosin (H&E) staining and immunohistochemistry were performed to investigate tissue pathology. Serum tumor necrosis factor-α levels, liver stiffness (LS), and the L3 skeletal muscle index (L3SMI) were measured in 60 patients with chronic liver disease.Results: LC and sarcopenia were successfully induced by TAA. Serum TNF-α levels were increased in LC rats and correlated with myostatin expression, muscle weight, and myofiber diameter. The expression of intestinal occludin and zona occludens-1 was reduced in LC rats and associated with serum TNF-α levels and sarcopenia. In patients with LS ≥7 kPa or sarcopenia, serum TNF-α levels were significantly increased, which was also confirmed when we raised the LS cutoff to 10 kPa. The L3SMI was inversely correlated with serum TNF-α levels in patients with LS ≥7 kPa. TNF-α was reduced by rifaximin, which might have resulted in reduced expression of muscular MuRF1 and myostatin and improvements in myofiber diameters within muscle tissues.Conclusions: These results suggest that serum TNF-α is associated with LC-related sarcopenia. Rifaximin might be effective in reducing serum TNF-α levels and improving sarcopenia in LC, but these results need to be validated in future studies.
- Published
- 2022